Galectin Therapeutics

GALT

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-42.43M

EBITDA$-41.47M

EBIT$-41.51M

Pre-tax Income$-26.25M

Net Income$-47.05M

Cash Equivalent$22.83M

Total Debt$96.67M

Book Value$-87.2M

Book Value Per Share-1.40

Return on Equity (ROE)-1165.27%

Return on Assets (ROA)-268.92%

Return on Invested Capital (ROI)-96.40%

Net Profit Marginundefined

Current Ratio0.49

Quick Ratio0.43

Long-Term Debt / Equity11.09